COVID-19 Therapeutics Fact Sheets and Guidance

COVID-19 Oral Antivirals have transitioned to the Commercial Marketplace

The federal government has shifted COVID-19 oral antiviral treatments Paxlovid (nirmatrelvir packaged with ritonavir) and Lagevrio (molnupiravir) to the commercial market. For information on upcoming milestones and timelines, please refer to:

Patient and Provider Fact Sheets from ASPR

Federal Resources